WELL Health to Participate in the Stifel GMP Muskoka Institutional Investor Conference
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
WELL Health Technologies Corp. (WHTCF) announced the participation of CEO Hamed Shahbazi in the 1st Annual Stifel GMP Muskoka Institutional Investor Conference, scheduled from July 13 to 15, 2022, at the JW Marriott The Rosseau Muskoka Resort & Spa, Minett, ONT. Mr. Shahbazi will hold one-on-one meetings with institutional investors on July 14. WELL is dedicated to enhancing health outcomes through technology, operating Canada's largest outpatient medical clinic network and a leading telehealth service. For details, refer to the official announcement.
Details
News Market Reaction – WHTCF
The recorded move for WHTCF in the trading session of this news was -4.80%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
VANCOUVER, BC, July 5, 2022 /PRNewswire/ - WELL Health Technologies Corp. (TSX: WELL) ("WELL" or the "Company"), a company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that Hamed Shahbazi, Chairman and CEO, will be participating in the 1st Annual Stifel GMP Muskoka Institutional Investor Conference.
The conference will take place in person at the JW Marriott The Rosseau Muskoka Resort & Spa in Minett, ONT, on July 13th to 15th, 2022. Mr. Shahbazi will be participating in one-on-one meetings with institutional investors on July 14th.
To register for the event, please contact your Stifel GMP representative.
Per: "Hamed Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and Director
WELL is a practitioner focused digital health company whose overarching objective is to positively impact health outcomes to empower and support healthcare practitioners and their patients. WELL has built an innovative practitioner enablement platform that includes comprehensive end to end practice management tools inclusive of virtual care and digital patient engagement capabilities as well as Electronic Medical Records (EMR), Revenue Cycle Management (RCM) and data protection services. WELL uses this platform to power healthcare practitioners both inside and outside of WELL's own omni-channel patient services offerings. As such, WELL owns and operates Canada's largest network of outpatient medical clinics serving primary and specialized healthcare services and is the provider of a leading multi-national, multi-disciplinary telehealth offering. WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL" and trades on the OTCQX under the symbol "WHTCF". To learn more about the Company, please visit: www.well.company.
View original content to download multimedia:https://www.prnewswire.com/news-releases/well-health-to-participate-in-the-stifel-gmp-muskoka-institutional-investor-conference-301580382.html
SOURCE WELL Health Technologies Corp.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.